Literature DB >> 8207830

Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.

R J Lenhoff1, J Summers.   

Abstract

We have used linker scanning and site-directed mutagenesis in an attempt to distinguish among the known functions of the duck hepatitis B virus large envelope protein, p36. We found that linker-encoded amino acid substitutions in at least one region of the pre-S envelope protein p36 produced defects in both the production of enveloped virus and the regulation of covalently closed circular DNA (cccDNA) synthesis. Most linker substitutions, typically in the 5' two-thirds of the pre-S region of the p36 gene did not affect either cccDNA regulation or enveloped virus production but did destroy the infection competence of the enveloped particles produced. Single amino acid substitutions of residues 128 and 131 demonstrated a similar correlation between defects in the ability of p36 to support enveloped virus production and to control cccDNA levels. We concluded from these studies that virus production and cccDNA regulation probably require a common activity of p36.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207830      PMCID: PMC236383     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide.

Authors:  J C Pugh; J W Summers
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences.

Authors:  E Mandart; A Kay; F Galibert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

6.  Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.

Authors:  H J Schlicht; C Kuhn; B Guhr; R J Mattaliano; H Schaller
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription.

Authors:  M Büscher; W Reiser; H Will; H Schaller
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

8.  Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH.

Authors:  T Kawaguchi; K Nomura; Y Hirayama; T Kitagawa
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

9.  The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

10.  Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particles.

Authors:  J C Pugh; J J Sninsky; J W Summers; E Schaeffer
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

View more
  75 in total

1.  Low dynamic state of viral competition in a chronic avian hepadnavirus infection.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Frequency of spontaneous mutations in an avian hepadnavirus infection.

Authors:  I Pult; N Abbott; Y Y Zhang; J Summers
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.

Authors:  W Yang; J Summers
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.

Authors:  L Luckenbaugh; K M Kitrinos; W E Delaney; J Hu
Journal:  J Viral Hepat       Date:  2014-11-14       Impact factor: 3.728

5.  Intracellular hepadnavirus nucleocapsids are selected for secretion by envelope protein-independent membrane binding.

Authors:  H Mabit; H Schaller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Hepatitis B virus core gene mutations which block nucleocapsid envelopment.

Authors:  M Koschel; D Oed; T Gerelsaikhan; R Thomssen; V Bruss
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 7.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

8.  Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection.

Authors:  S Tong; J Li; J R Wands
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.

Authors:  Anne Marie Dougherty; Haitao Guo; Gael Westby; Yuanjie Liu; Ender Simsek; Ju-Tao Guo; Anand Mehta; Pamela Norton; Baohua Gu; Timothy Block; Andrea Cuconati
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

10.  Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.

Authors:  Kathie-Anne Walters; Michael A Joyce; William R Addison; Karl P Fischer; D Lorne J Tyrrell
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.